Janus Henderson Group’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Sell |
3,684,383
-873,537
| -19% | -$3.52M | 0.01% | 629 |
|
|
2025
Q1 | $18.6M | Buy |
4,557,920
+218,666
| +5% | +$893K | 0.01% | 582 |
|
|
2024
Q4 | $28.5M | Buy |
4,339,254
+576,059
| +15% | +$3.78M | 0.01% | 511 |
|
|
2024
Q3 | $34M | Buy |
3,763,195
+599,203
| +19% | +$5.41M | 0.02% | 466 |
|
|
2024
Q2 | $50.7M | Buy |
3,163,992
+623,207
| +25% | +$9.99M | 0.03% | 382 |
|
|
2024
Q1 | $39.8M | Buy |
2,540,785
+210,047
| +9% | +$3.29M | 0.02% | 434 |
|
|
2023
Q4 | $31.3M | Buy |
+2,330,738
| New | +$31.3M | 0.02% | 466 |
|